Caribou Biosciences (CRBU) Deferred Taxes (2020)

Caribou Biosciences' (CRBU) quarterly Deferred Taxes came in at $57000.0 in Q4 2020, up 126.76% on a QoQ basis from -$213000.0 in Q3 2020.

Caribou Biosciences (CRBU) Deferred Taxes (2020) Analysis & Trends

Caribou Biosciences (CRBU) has 1 years of Deferred Taxes data on file, last reported at $57000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -188,883.60
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -65.30 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 96.00 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Caribou Biosciences 156.25 Mn 38.63 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 57,000.00
Sep 30, 2020 -213,000.00